Categories: Research

School of Pharmacy leads in NIH funding for the 44th straight year

School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.

Guo named inaugural director of new Center for Collaborative Innovation

Su Guo, PhD, will lead a new center to increase collaboration between clinical, translational, and discovery science in teaching and research.

PharmD program creates new opportunities to explore industry and research career paths

Students keep pace with latest innovations through experiential options and advanced degrees.

Kortemme named new vice dean of research

Computational biology and protein engineering expert will focus on cultivating collaboration.

QBI and Director Krogan’s COVID and infectious disease efforts continue to make waves

QBI publishes breakthrough on COVID-19 variants; Nevan Krogan recognized as trailblazer.

The Kidney Project proves its bioreactor can keep kidney cells alive for at least one week

Scientists have shown for the first time that kidney cells—housed in an implantable device called a bioreactor—can survive while implanted.

A budding partnership with Korean regulatory science pharmacists

A delegation from South Korea visited to sign a Memorandum of Understand (MOU) initiating potential collaborations between UCSF and Korean schools of pharmacy.

Innovation gets a boost from 2023 Koda-Kimble Seed Awards

This ninth year of awards focuses on research advancing health and furthering understanding related to cancer, diabetes, HIV testing, immune response, and more.

Regulatory science at UCSF gets major boost with FDA CERSI renewal

The FDA announces the Centers of Excellence in Regulatory Science and Innovation (CERSI) renewals, granting up to $50M for UCSF’s joint effort with Stanford.

Scaling up the bioartificial kidney at UCSF

On June 12, The Kidney Project was awarded a $1 million Artificial Kidney Prize from KidneyX for advancing its prototype bioartificial kidney toward a full-sized, human scale, with manufacturing and ultimately clinical trials on the horizon.

Pages